Zoetis Inc. (VIE:ZOTS)

Austria flag Austria · Delayed Price · Currency is EUR
124.88
-0.44 (-0.35%)
At close: Oct 3, 2025
-0.35%
Market Cap55.49B
Revenue (ttm)7.99B
Net Income (ttm)2.22B
Shares Outn/a
EPS (ttm)4.95
PE Ratio24.95
Forward PE22.44
Dividend1.75 (1.40%)
Ex-Dividend DateJul 18, 2025
Volumen/a
Average Volume5
Open125.34
Previous Close125.32
Day's Range124.88 - 126.00
52-Week Range119.74 - 181.56
Betan/a
RSI47.61
Earnings DateNov 4, 2025

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph... [Read more]

Industry Pharmaceutical Preparations
Founded 1950
Employees 13,800
Stock Exchange Vienna Stock Exchange
Ticker Symbol ZOTS
Full Company Profile

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD Financial Statements

News

There is no news available yet.